attento is a combined drug that contains olmesartan medoxomil, an antagonist of angiotensin II receptors and amlodipine besilate, a calcium channel blocker. The combination of these two active substances leads to a synergistic effect and a decrease in the level of adhesion to a greater extent than any active substance separately.